Skip to content

Mobile-assisted Medication Adherence Support (Ma-MAS) Intervention for Tuberculosis Patients in Addis Ababa, Ethiopia.

Mobile-assisted Medication Adherence Support (Ma-MAS) Intervention among Tuberculosis Patients in Addis Ababa, Ethiopia; Randomized Control Trial (RCT)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202002831201865
Enrollment
186
Registered
2020-02-18
Start date
2021-03-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

SMS text plus phone calls
Non daily DOT alone

Sponsors

Flinders University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: To be included into the randomized control trial (RCT) • participants must be enrolled in a primary public health facility for anti-TB treatment and have attained their first two months of the intensive phase of treatment • participants must be aged 18 years and above • participants must be able to read and understand SMS text that is written in the national official language (Amharic) of Ethiopia • participants must have their own mobile phone, or • participants who do not have a mobile phone can be included if they have a shared mobile phone in the household with a collaborative agreement; (i.e. a voluntary agreement between the patient and family member living in the same household).

Exclusion criteria

Exclusion criteria: Participants will be excluded from the randomized trial if they meet the following conditions: Patients whose anti-tuberculosis treatment prescribed for more than six months of treatment. Patients who unable to read and speak the national official language of Ethiopia. Patients who enrolled or agreed to enroll in another trial study as the same time with this study.

Design outcomes

Primary

MeasureTime frame
TB medication adherence measured by IsoScreen test

Secondary

MeasureTime frame
TB medication adherence measured by ACTG, VAS and clinical attendance

Countries

Ethiopia

Contacts

Public ContactYohannes Dr

Addis Ababa Health Bureau Human Research Ethics committee coordinator

yoha2wok@yahoo.com251911384599

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026